212 related articles for article (PubMed ID: 9001297)
1. Inhaled salmeterol or oral theophylline in nocturnal asthma?
Selby C; Engleman HM; Fitzpatrick MF; Sime PM; Mackay TW; Douglas NJ
Am J Respir Crit Care Med; 1997 Jan; 155(1):104-8. PubMed ID: 9001297
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
Ukena D; Koper I; Braun H; Leutz M; Schlimmer P; Sybrecht GW
Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease.
Fjellbirkeland L; Gulsvik A; Palmer JB
Respir Med; 1994 Sep; 88(8):599-607. PubMed ID: 7991885
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
[TBL] [Abstract][Full Text] [Related]
7. [Inhaled salmeterol or oral theophylline in nocturnal asthma?].
Ukena D
Pneumologie; 1997 Sep; 51(9):919-20. PubMed ID: 9411444
[No Abstract] [Full Text] [Related]
8. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group.
Paggiaro PL; Giannini D; Di Franco A; Testi R
Eur Respir J; 1996 Aug; 9(8):1689-95. PubMed ID: 8866596
[TBL] [Abstract][Full Text] [Related]
11. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group.
Muir JF; Bertin L; Georges D
Eur Respir J; 1992 Nov; 5(10):1197-200. PubMed ID: 1486965
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline.
Nutini S; Martini T; Righi R
Respir Med; 1998 Apr; 92(4):683-90. PubMed ID: 9659537
[TBL] [Abstract][Full Text] [Related]
14. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease.
Ryan S; Doherty LS; Rock C; Nolan GM; McNicholas WT
Respiration; 2010; 79(6):475-81. PubMed ID: 19684384
[TBL] [Abstract][Full Text] [Related]
15. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol versus theophylline in the treatment of asthma.
Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
[TBL] [Abstract][Full Text] [Related]
17. An evaluative study of the short-term effects of once-daily, sustained-release theophylline on sleep in nocturnal asthmatics.
Richardt D; Driver HS
S Afr Med J; 1996 Jul; 86(7):803-4. PubMed ID: 8764904
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline.
Zwillich CW; Neagley SR; Cicutto L; White DP; Martin RJ
Am Rev Respir Dis; 1989 Feb; 139(2):470-4. PubMed ID: 2643904
[TBL] [Abstract][Full Text] [Related]
19. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
Evans DJ; Taylor DA; Zetterstrom O; Chung KF; O'Connor BJ; Barnes PJ
N Engl J Med; 1997 Nov; 337(20):1412-8. PubMed ID: 9358138
[TBL] [Abstract][Full Text] [Related]
20. Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
Inoue H; Komori M; Matsumoto T; Fukuyama S; Matsumura M; Nakano T; Tsuda M; Matsumoto K; Kanaya A; Moriwaki A; Aizawa H; Yoshida M; Nakanishi Y
Respiration; 2007; 74(6):611-6. PubMed ID: 16960440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
